These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 14580658

  • 1. Topiramate concentration in saliva: an alternative to serum monitoring.
    Miles MV, Tang PH, Glauser TA, Ryan MA, Grim SA, Strawsburg RH, deGrauw TJ, Baumann RJ.
    Pediatr Neurol; 2003 Aug; 29(2):143-7. PubMed ID: 14580658
    [Abstract] [Full Text] [Related]

  • 2. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E.
    Clin Pharmacokinet; 2005 Aug; 44(4):407-16. PubMed ID: 15828853
    [Abstract] [Full Text] [Related]

  • 3. Plasma concentration of topiramate correlates with cerebrospinal fluid concentration.
    Christensen J, Højskov CS, Dam M, Poulsen JH.
    Ther Drug Monit; 2001 Oct; 23(5):529-35. PubMed ID: 11591899
    [Abstract] [Full Text] [Related]

  • 4. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.
    May TW, Rambeck B, Jürgens U.
    Ther Drug Monit; 2002 Jun; 24(3):366-74. PubMed ID: 12021627
    [Abstract] [Full Text] [Related]

  • 5. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C, De Smedt H, Stockis A.
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [Abstract] [Full Text] [Related]

  • 6. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Riva R, Albani F, Avoni P, Baruzzi A.
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [Abstract] [Full Text] [Related]

  • 7. Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response.
    Ferrari AR, Guerrini R, Gatti G, Alessandrì MG, Bonanni P, Perucca E.
    Ther Drug Monit; 2003 Dec; 25(6):700-8. PubMed ID: 14639056
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C, Baftiu A, Tysse I, Valsø B, Larsson PG, Rytter E, Johannessen SI.
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [Abstract] [Full Text] [Related]

  • 9. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations.
    Ohman I, Vitols S, Luef G, Söderfeldt B, Tomson T.
    Epilepsia; 2002 Oct; 43(10):1157-60. PubMed ID: 12366729
    [Abstract] [Full Text] [Related]

  • 10. Saliva and serum concentration of lamotrigine in patients with epilepsy.
    Tsiropoulos I, Kristensen O, Klitgaard NA.
    Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
    [Abstract] [Full Text] [Related]

  • 11. A nonlinear mixed effects modelling analysis of topiramate pharmacokinetics in patients with epilepsy.
    Vovk T, Jakovljević MB, Kos MK, Janković SM, Mrhar A, Grabnar I.
    Biol Pharm Bull; 2010 Oct; 33(7):1176-82. PubMed ID: 20606310
    [Abstract] [Full Text] [Related]

  • 12. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
    Takeuchi M, Yano I, Ito S, Sugimoto M, Yamamoto S, Yonezawa A, Ikeda A, Matsubara K.
    Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
    [Abstract] [Full Text] [Related]

  • 13. Age and antiepileptic drugs influence topiramate plasma levels in children.
    Dahlin MG, Ohman IK.
    Pediatr Neurol; 2004 Oct; 31(4):248-53. PubMed ID: 15464635
    [Abstract] [Full Text] [Related]

  • 14. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
    Mikaeloff Y, Rey E, Soufflet C, d'Athis P, Echenne B, Vallée L, Bouhours P, Grinspan A, Dulac O, Pons G, Chiron C.
    Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with topiramate dosing and serum levels in patients with epilepsy.
    Zanotta N, Raggi ME, Radice L, Degrate A, Bresolin N, Zucca C.
    Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695
    [Abstract] [Full Text] [Related]

  • 16. Lack of an effect of topiramate on lamotrigine serum concentrations.
    Berry DJ, Besag FM, Pool F, Natarajan J, Doose D.
    Epilepsia; 2002 Aug; 43(8):818-23. PubMed ID: 12180999
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG, Nandy P, Nye JS, Ford L, Mohanty S, Wang S, Ochalski S, Eerdekens M, Cox E.
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy.
    Schwabe MJ, Wheless JW.
    J Child Neurol; 2001 Nov; 16(11):806-8. PubMed ID: 11732765
    [Abstract] [Full Text] [Related]

  • 19. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE, Doose DR, Walker SA, Nayak RK.
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [Abstract] [Full Text] [Related]

  • 20. Topiramate pharmacokinetics in infants.
    Glauser TA, Miles MV, Tang P, Clark P, McGee K, Doose DR.
    Epilepsia; 1999 Jun; 40(6):788-91. PubMed ID: 10368080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.